Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00615771 · ClinicalTrials.gov registry record · NA
Day of Embryo Transfer for Patients Undergoing In Vitro Fertilization
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 242
- Enrollment target
NCT00615771: Completed NA study, sponsored by Stanford University.
NCT00615771 is a NA study that has completed, run by Stanford University. The registered enrollment target is 242 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00615771, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 242 participants
- Enrollment target
Study Summary
We are examining whether pregnancy rates differ based on day of embryo transfer in patients who replace all available embryos after an In vitro Fertilization (IVF) cycle. Patients must be undergoing IVF treatment at Stanford University and patients will not receive compensation for their participation (no medical costs covered or patient payment for participation).
Interventions
- PROCEDURE Day 3 embryo transfer
- PROCEDURE Day 2 embryo transfer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00615771
The ClinicalTrials.gov registry entry for NCT00615771 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Day 3 embryo transfer is the first listed.
NCT00615771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00615771 about?
NCT00615771 is a clinical study titled "Day of Embryo Transfer for Patients Undergoing In Vitro Fertilization". We are examining whether pregnancy rates differ based on day of embryo transfer in patients who replace all available embryos after an In vitro Fertilization (IVF) cycle. Patients must be undergoing IVF treatment at Stanford University and patients will not receive compensation for their participati...
What is the current status of trial NCT00615771?
This trial is currently completed. It is a NA study. The enrollment target is 242 participants. The study started on 2007-01. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00615771?
The interventions under investigation include: Day 3 embryo transfer (PROCEDURE), Day 2 embryo transfer (PROCEDURE).
Who is sponsoring clinical trial NCT00615771?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.